Treatment of the P3 selected LLC cells with 2.2 nM TSP1 suppressed expression of the same stem cell factors, decreased their spheroid formation, and increased their sensitivity to killing by tumor-specific CTL. This evidence concerns the gene THBS1 and neoplasm.